Finding 498105 (2020-010)

Material Weakness Repeat Finding
Requirement
C
Questioned Costs
-
Year
2023
Accepted
2024-09-24

AI Summary

  • Core Issue: The Organization lacks documented evidence of review and approval for drawdown requests, which may lead to non-compliance with federal funding requirements.
  • Impacted Requirements: Internal controls under 2 CFR Section 200.303(a) and reimbursement procedures outlined in 2 CFR Section 200.305(b)(3) are not being followed.
  • Recommended Follow-Up: Strengthen internal controls and implement processes to ensure all drawdown requests are properly reviewed and approved before reimbursement requests are made.

Finding Text

Federal Program Information: Funding Agency: U.S Department of Health and Human Services FALN: 93.926 Federal Award Identification Number: H49MC00119‐19‐00 Pass Through Entity: State of Georgia Department of Human Services Award Year: 2018‐2020 Criteria: Under 2 CFR Section 200.303(a), non‐federal entities must establish and maintain effective internal controls to provide reasonable assurance that the entity is managing the federal awards in compliance with statues, regulations, and the terms and conditions of the award. Additionally regulations require the reimbursement payment method may be used on a Federal award for activities as specified in 2 CFR section 200.305(b)(3), program costs must be paid by non‐ Federal entity funds before submitting a payment request (2 CFR section 200.305(b)(3)), i.e., the non‐ Federal entity must disburse funds for program purposes before requesting payment from the Federal awarding agency or pass‐through entity. Condition: The Organization has a policy which in includes thee Fiscal/Grant Manager and/or the CEO review all drawdown requests to ensure costs are paid before reimbursement is requested. However of the seventeen (17) drawdown requests that we tested, there was no evidence of review and approval for payment. Effect: Management possibly did not expend funds in accordance with the federal award due to lack of evidence of oversight/review of drawdowns and after reimbursable expenses have been incurred. Cause: Management did not document evidence of review and approval of drawdown requests. This was due in part to lack of oversight. Also there were several changes in personnel within the accounting area and overall limited number of personnel for certain functions and lack of board oversight. Questioned costs: None Recommendation: We recommend that internal controls be strengthened and processes implemented to ensure all draw down requests are reviewed and approved to ensure costs were accurately reported and paid before requesting reimbursement.

Corrective Action Plan

We concur with this finding and have implemented measures to mitigate the repetition or additional occurrences. In 2023, we implemented additional procedures to more efficiently review drawdowns and supporting documentation. We updated our fiscal policies and procedures in 2023 to document a standardized process for review and approval of drawdowns before request for reimbursement by the Fiscal Office and CEO. Responsible person(s): Jemea Dorsey, CEO and Jeanetta Johnson, Fiscal Manager Anticipated Completion Date: FY 2022

Categories

Cash Management Internal Control / Segregation of Duties

Other Findings in this Audit

  • 498102 2020-007
    Significant Deficiency Repeat
  • 498103 2020-008
    Material Weakness Repeat
  • 498104 2020-009
    Material Weakness Repeat
  • 498106 2020-011
    Significant Deficiency Repeat
  • 498107 2020-012
    Material Weakness Repeat
  • 498108 2020-007
    Significant Deficiency Repeat
  • 498109 2020-008
    Material Weakness Repeat
  • 498110 2020-009
    Material Weakness Repeat
  • 498111 2020-010
    Material Weakness Repeat
  • 498112 2020-011
    Significant Deficiency Repeat
  • 498113 2020-012
    Material Weakness Repeat
  • 1074544 2020-007
    Significant Deficiency Repeat
  • 1074545 2020-008
    Material Weakness Repeat
  • 1074546 2020-009
    Material Weakness Repeat
  • 1074547 2020-010
    Material Weakness Repeat
  • 1074548 2020-011
    Significant Deficiency Repeat
  • 1074549 2020-012
    Material Weakness Repeat
  • 1074550 2020-007
    Significant Deficiency Repeat
  • 1074551 2020-008
    Material Weakness Repeat
  • 1074552 2020-009
    Material Weakness Repeat
  • 1074553 2020-010
    Material Weakness Repeat
  • 1074554 2020-011
    Significant Deficiency Repeat
  • 1074555 2020-012
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.926 Healthy Start Initiative $734,166
93.110 Maternal and Child Health Federal Consolidated Programs $28,089
14.218 Community Development Block Grants/entitlement Grants $22,413
93.426 Improving the Health of Americans Through Prevention and Management of Diabetes and Heart Disease and Stroke $4,145